[
    [
        {
            "time": "2021-08-28",
            "original_text": "智飞生物独家新冠疫苗数据发布：重症保护率100%，对Delta超77%",
            "features": {
                "keywords": [
                    "智飞生物",
                    "新冠疫苗",
                    "重症保护率",
                    "Delta",
                    "100%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "智飞生物独家新冠疫苗数据发布：重症保护率100%，对Delta超77%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-08-28",
            "original_text": "智飞生物发布新冠疫苗Ⅲ期临床数据：Alpha保护率92.93% Delta保护率77.54%",
            "features": {
                "keywords": [
                    "智飞生物",
                    "新冠疫苗",
                    "Ⅲ期临床",
                    "Alpha",
                    "Delta",
                    "92.93%",
                    "77.54%"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "智飞生物发布新冠疫苗Ⅲ期临床数据：Alpha保护率92.93% Delta保护率77.54%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-08-28",
            "original_text": "上市公司正面新闻2021年8月28日星期六",
            "features": {
                "keywords": [
                    "上市公司",
                    "正面新闻"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上市公司正面新闻2021年8月28日星期六",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 2,
                "Impact": 2,
                "Duration": 2,
                "Entity_Density": 1,
                "Market_Scope": 4,
                "Time_Proximity": 3,
                "Headline_Structure": 4,
                "Source_Recency": 2
            }
        }
    ]
]